🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
Late 2013, the first indigenous cases of chikungunya have been observed in ...
Status
Completed
Location
CHU de Guadeloupe
Start Date
2015-02
Trial ID
NCT02553369
Treatments Being Tested
To prospectively collect blood and tumor tissue from esophageal cancer pati...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2017-10-01
Trial ID
NCT03108885
Treatments Being Tested
This phase III trial compares the effect of adding cabozantinib to avelumab...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2022-06-03
Trial ID
NCT05092958
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
The need to obtain human tissue for methods development and disease correla...
Status
Recruiting
Location
National Institute of Aging, Clinical Research Unit
Start Date
2003-06-26
Trial ID
NCT00182858
French prospective multicenter, open-label study involving newly diagnosed ...
Status
Recruiting
Location
CHU Annecy-Genevois
Start Date
2023-11-17
Trial ID
NCT06130787
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
The purpose of this study is to constitute the French largest Aggressive fi...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest - Paul Papin
Start Date
2016-03-22
Trial ID
NCT02867033